INBX insider transactions
Inhibrx Biosciences Inc. (INBX) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.
Recent Form 3, 4, and 5 filings for INBX
- SEC Form 4 filed by Inhibrx Biosciences Inc.4 - Inhibrx Biosciences, Inc. (0002007919) (Issuer)
- Chief Executive Officer Lappe Mark bought $998,784 worth of shares (10,000 units at $99.88) (SEC Form 4)4 - Inhibrx Biosciences, Inc. (0002007919) (Issuer)
- Director Kayyem Jon Faiz bought $500,000 worth of shares (5,000 units at $100.00) (SEC Form 4)4 - Inhibrx Biosciences, Inc. (0002007919) (Issuer)
- Amendment: SEC Form 4 filed by Director Forsyth Douglas4/A - Inhibrx Biosciences, Inc. (0002007919) (Issuer)
- Amendment: SEC Form 4 filed by Director Vuori Kristiina Md4/A - Inhibrx Biosciences, Inc. (0002007919) (Issuer)
- Amendment: SEC Form 4 filed by Director Manhard Kimberly4/A - Inhibrx Biosciences, Inc. (0002007919) (Issuer)
- Amendment: SEC Form 4 filed by Director Kayyem Jon Faiz4/A - Inhibrx Biosciences, Inc. (0002007919) (Issuer)
- Director Kayyem Jon Faiz bought $500,000 worth of shares (5,000 units at $100.00) (SEC Form 4)4 - Inhibrx Biosciences, Inc. (0002007919) (Issuer)
- Director Manhard Kimberly sold $163,542 worth of shares (1,500 units at $109.03) (SEC Form 4)4 - Inhibrx Biosciences, Inc. (0002007919) (Issuer)
- Director Manhard Kimberly sold $115,468 worth of shares (1,000 units at $115.47) (SEC Form 4)4 - Inhibrx Biosciences, Inc. (0002007919) (Issuer)
- Director Kayyem Jon Faiz bought $567,580 worth of shares (5,000 units at $113.52) (SEC Form 4)4 - Inhibrx Biosciences, Inc. (0002007919) (Issuer)
- Director Forsyth Douglas bought $286,617 worth of shares (2,500 units at $114.65) (SEC Form 4)4 - Inhibrx Biosciences, Inc. (0002007919) (Issuer)
- Chief Executive Officer Lappe Mark bought $2,645,399 worth of shares (25,000 units at $105.82) (SEC Form 4)4 - Inhibrx Biosciences, Inc. (0002007919) (Issuer)
- SEC Form 4 filed by Director Vuori Kristiina Md4 - Inhibrx Biosciences, Inc. (0002007919) (Issuer)
- SEC Form 4 filed by Director Kayyem Jon Faiz4 - Inhibrx Biosciences, Inc. (0002007919) (Issuer)
- SEC Form 4 filed by Director Forsyth Douglas4 - Inhibrx Biosciences, Inc. (0002007919) (Issuer)
- SEC Form 4 filed by Director Manhard Kimberly4 - Inhibrx Biosciences, Inc. (0002007919) (Issuer)
- SEC Form 4 filed by President Matly David4 - Inhibrx Biosciences, Inc. (0002007919) (Issuer)
- Large owner Viking Global Investors Lp sold $11,287,500 worth of shares (350,000 units at $32.25) (SEC Form 4)4 - Inhibrx Biosciences, Inc. (0002007919) (Issuer)
- SEC Form 4 filed by Director Manhard Kimberly4 - Inhibrx Biosciences, Inc. (0002007919) (Issuer)
- SEC Form 4 filed by Director Vuori Kristiina Md4 - Inhibrx Biosciences, Inc. (0002007919) (Issuer)
- SEC Form 4 filed by Director Kayyem Jon Faiz4 - Inhibrx Biosciences, Inc. (0002007919) (Issuer)
- SEC Form 4 filed by Director Forsyth Douglas4 - Inhibrx Biosciences, Inc. (0002007919) (Issuer)
- SEC Form 4 filed by Chief Financial Officer Deck Kelly4 - Inhibrx Biosciences, Inc. (0002007919) (Issuer)
- SEC Form 4 filed by President Matly David4 - Inhibrx Biosciences, Inc. (0002007919) (Issuer)
- SEC Form 3 filed by new insider Matly David3 - Inhibrx Biosciences, Inc. (0002007919) (Issuer)
- Director Kayyem Jon Faiz gifted 90,000 shares (SEC Form 4)4 - Inhibrx Biosciences, Inc. (0002007919) (Issuer)
- Director Kayyem Jon Faiz gifted 500,000 shares and received a gift of 500,000 shares (SEC Form 4)4 - Inhibrx Biosciences, Inc. (0002007919) (Issuer)
- Director Kayyem Jon Faiz gifted 52,000 shares (SEC Form 4)4 - Inhibrx Biosciences, Inc. (0002007919) (Issuer)
- Director Kayyem Jon Faiz bought $1,523,620 worth of shares (107,186 units at $14.21) (SEC Form 4)4 - Inhibrx Biosciences, Inc. (0002007919) (Issuer)
- Director Vuori Kristiina Md bought $100,005 worth of shares (6,667 units at $15.00), increasing direct ownership by 48% to 20,443 units (SEC Form 4)4 - Inhibrx Biosciences, Inc. (0002007919) (Issuer)
- Chief Executive Officer Lappe Mark bought $629,117 worth of shares (40,000 units at $15.73) (SEC Form 4)4 - Inhibrx Biosciences, Inc. (0002007919) (Issuer)
- Director Vuori Kristiina Md bought $99,992 worth of shares (6,636 units at $15.07), increasing direct ownership by 93% to 13,776 units (SEC Form 4)4 - Inhibrx Biosciences, Inc. (0002007919) (Issuer)
- Chief Executive Officer Lappe Mark bought $671,150 worth of shares (44,000 units at $15.25) (SEC Form 4)4 - Inhibrx Biosciences, Inc. (0002007919) (Issuer)
- Chief Executive Officer Lappe Mark bought $596,763 worth of shares (40,000 units at $14.92) (SEC Form 4)4 - Inhibrx Biosciences, Inc. (0002007919) (Issuer)
- Director Vuori Kristiina Md bought $99,960 worth of shares (7,140 units at $14.00) (SEC Form 4)4 - Inhibrx Biosciences, Inc. (0002007919) (Issuer)
- Director Manhard Kimberly bought $139,800 worth of shares (10,000 units at $13.98) (SEC Form 4)4 - Inhibrx Biosciences, Inc. (0002007919) (Issuer)
- Director Forsyth Douglas bought $1,037,328 worth of shares (75,000 units at $13.83) (SEC Form 4)4 - Inhibrx Biosciences, Inc. (0002007919) (Issuer)
- Chief Executive Officer Lappe Mark bought $518,282 worth of shares (40,000 units at $12.96) (SEC Form 4)4 - Inhibrx Biosciences, Inc. (0002007919) (Issuer)
- Inhibrx, Inc. disposed of 13,316,140 shares, decreasing direct ownership by 92% to 1,157,926 units (SEC Form 4)4 - Inhibrx, Inc. (0001739614) (Reporting)
- SEC Form 4 filed by Vuori Kristiina Md4 - Inhibrx, Inc. (0001739614) (Issuer)
- SEC Form 4 filed by Manhard Kimberly4 - Inhibrx, Inc. (0001739614) (Issuer)
- Lappe Mark returned $91,369,620 worth of shares to the company (3,045,654 units at $30.00) (SEC Form 4)4 - Inhibrx, Inc. (0001739614) (Issuer)
- Kayyem Jon Faiz returned $98,229,030 worth of shares to the company (3,274,301 units at $30.00) (SEC Form 4)4 - Inhibrx, Inc. (0001739614) (Issuer)
- Eckelman Brendan P. sold $10,290,000 worth of shares (300,000 units at $34.30) and returned $61,666,590 worth of shares to the company (2,055,553 units at $30.00) (SEC Form 4)4 - Inhibrx, Inc. (0001739614) (Issuer)
- SEC Form 4 filed by Deck Kelly4 - Inhibrx, Inc. (0001739614) (Issuer)
- Forsyth Douglas returned $17,947,710 worth of shares to the company (598,257 units at $30.00) (SEC Form 4)4 - Inhibrx, Inc. (0001739614) (Issuer)
- SEC Form 4 filed by Eckelman Brendan P.4 - Inhibrx, Inc. (0001739614) (Issuer)
- New insider Inhibrx, Inc. claimed ownership of 100 shares (SEC Form 3)3 - Inhibrx, Inc. (0001739614) (Reporting)
- SEC Form 4 filed by Deck Kelly4 - Inhibrx, Inc. (0001739614) (Issuer)
- SEC Form 4 filed by Deck Kelly4 - Inhibrx, Inc. (0001739614) (Issuer)
- SEC Form 4 filed by Deck Kelly4 - Inhibrx, Inc. (0001739614) (Issuer)
- SEC Form 4 filed by Eckelman Brendan P.4 - Inhibrx, Inc. (0001739614) (Issuer)
- SEC Form 4 filed by Deck Kelly4 - Inhibrx, Inc. (0001739614) (Issuer)
- SEC Form 4 filed by Eckelman Brendan P.4 - Inhibrx, Inc. (0001739614) (Issuer)
- SEC Form 4 filed by Deck Kelly4 - Inhibrx, Inc. (0001739614) (Issuer)
- SEC Form 4 filed by Deck Kelly4 - Inhibrx, Inc. (0001739614) (Issuer)
- SEC Form 4: Viking Global Investors Lp bought $9,899,982 worth of shares (511,627 units at $19.35)4 - Inhibrx, Inc. (0001739614) (Issuer)
- SEC Form 4 filed by Forsyth Douglas4 - Inhibrx, Inc. (0001739614) (Issuer)
- SEC Form 4 filed by Vuori Kristiina Md4 - Inhibrx, Inc. (0001739614) (Issuer)